News Chart Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-06-04 am EDT			5-day change	1st Jan Change
326.30 ^DKK	+9.02%		+0.43%	-30.04%

Jun. 05	Zealand touts promising tolerability data for obesity drug in mid-stage study	RE
Jun. 05	Zealand Pharma A/S Presents Additional Data From Phase 2 ZUPREME-1 Trial Evaluating Petrelintide At The American Diabetes Association 2026 Scientific Sessions	CI

7cb4b7522f3a38a0.D8dLz8LpQcePtj7ki64wbTXSK3QvkG8RUBobaDSUwLM.fYAC9peKDKPO20qpuchYOXOgZwNs4BhXInZKGnbxstZttC29jYMijr_nVQ~4e0d3d92e6a801fa8cc37d30b12e4a50